ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/09/2025
Voltar para busca
Dado oficial do USPTO
AVITA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
03/09/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 36, 39, 44
Data de depósito
01/12/2020
Data de registro
07/06/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/06/2022
Última transação
03/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
11/03/2021
Primeiro uso no comércio
11/03/2021
Código do desenho
3
Tipo de titular
16
Localização do titular
Baton Rouge, LA
Examinador
RIEPEL, CHRISTINA
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of stylized design of three interlocking hearts with the term "AVITA" next to it.
Titulares e representantes
Titulares
Avita Drugs, LLC
Representantes
Mary Mazzello Kirkland & Ellis LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 39Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Pharmacy servicescoordinating filling and refilling prescriptionsgenerating reports to patientsprescriberscare givers regarding prescriptionsassisting with pharmaceutical drug billing; retail pharmacy services; pharmaceutical cost management advisory and consulting services and drug utilization review advisory and consulting servicesenhancing access to low-cost pharmaceuticals for the medically underserved and supporting not-for-profit hospitals and health centers in administering and maximizing the use of the federal 340B prescription drug discount program to reduce pharmaceutical costs and improve the health status of their patients; administration and management of third party use of the federal 340B prescription drug discount programassisting with registrationreportingbusiness auditingcoordination and assignment of benefitsmedication inventory management; pharmacy discount card servicesadministration of a discount programs for enabling participants to obtain discounts on pharmaceutical goods through the use of a discount membership card; retail pharmacy services340B contract pharmacy services
Classe 36
Facilitating and coordinating insurance authorization for prescriptions between and among patientsdoctorscare-givers and insurancecommunicating with patients regarding prescription cost and insurance coverage of prescription drugs; administration and management of third party use of the federal 340B prescription drug discount programbill payment services and debt collections services
Classe 39
Prescription delivery servicesadministration and management of third party use of the federal 340B prescription drug discount programmedication delivery servicesdelivery and packing of goods for transport purposes pursuant to compliance regulations
Classe 44
Patient medication care management and medication adherence servicescounseling patients regarding their medicationsadherence to medication regimensmedication side-effectsallergic sensitivitydrug interactionsother issues related to medication tolerancealternate medication brands or genericsdosage or manner of taking medications; coordinating and implementing information and instructions regarding patients' medication regimen and adherence theretomedication needs and issuesconsideration of generic or alternative medicationsbetween and among patientsdoctorscare-givers and insurance; coordinating patient medication care management information and facilitating adherence to medication regimensbetween and among patientsdoctorscare-givers and insurance; dispensing medication under the federal 340B prescription drug discount program; administration and management of third party use of the federal 340B prescription drug discount programmedication services in the nature of administration of medication medicating to patients and prescription refill reminder services
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
21/02/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/02/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/02/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/02/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/06/2022
DOCK
ASSIGNED TO EXAMINER
27/05/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/05/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/05/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
22/03/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
22/03/2022
IUAF
USE AMENDMENT FILED
24/02/2022
EISU
TEAS STATEMENT OF USE RECEIVED
24/02/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/02/2022
EX1G
SOU EXTENSION 1 GRANTED
14/02/2022
EXT1
SOU EXTENSION 1 FILED
14/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
14/02/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
24/08/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/06/2021
PUBO
PUBLISHED FOR OPPOSITION
29/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/05/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
21/05/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/05/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
21/05/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/05/2021
DOCK
ASSIGNED TO EXAMINER
17/05/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2021
NWAP
NEW APPLICATION ENTERED
04/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AVITA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.